CN1173372A - External-use medicines for treating gynaopathy and its prepn. method - Google Patents

External-use medicines for treating gynaopathy and its prepn. method Download PDF

Info

Publication number
CN1173372A
CN1173372A CN 97116339 CN97116339A CN1173372A CN 1173372 A CN1173372 A CN 1173372A CN 97116339 CN97116339 CN 97116339 CN 97116339 A CN97116339 A CN 97116339A CN 1173372 A CN1173372 A CN 1173372A
Authority
CN
China
Prior art keywords
rhizoma
fructus
cortex
powder
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97116339
Other languages
Chinese (zh)
Inventor
洪玉美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97116339 priority Critical patent/CN1173372A/en
Publication of CN1173372A publication Critical patent/CN1173372A/en
Pending legal-status Critical Current

Links

Abstract

An externally-used medicine for curing gynopathy is prepared from 23 Chinese-medicinal materials such as pangolin scales, siphonostegia, corydalis tuber, giant knotweed rhizome, trogopterus dung, etc, and features its functions of improving blood circulation in pelvic tissue and immunity, changing the metabolism of pelvic tissue organs, and promoting the modification of anoxia state of local tissue cells.

Description

Treat gynopathic external used medicine and preparation method thereof
The invention belongs to the gynopathic external used medicine of a kind of treatment, particularly relating to a kind of is the Chinese patent medicine and preparation method thereof of feedstock production with the Chinese herbal medicine.
Gynaecopathia is the common frdquently encountered disease of serious harm WomanHealth, especially the treatment of chronic cervicitis (cervical erosion) is a worldwide medical difficult problem, cervical erosion more can not brought out cervical cancer for a long time, and chronic pelvic inflammatory disease can cause the patient not healed all the life, and the women is caused great misery.
The domestic and international at present difficulty that exists some to be difficult to overcome to gynopathic treatment:
1, antibiotics treatment chronic pelvic inflammatory disease produces little effect; Drug resistance is strong, and causes the vaginal microbial flora disorder easily.
2, oral Chinese patent medicine, because the pelvic tissue slow blood flow adds the effect of first outpost of the tax office, the patient often can not take medicine for a long time;
3, cervicitis (cervical erosion) all adopts the vagina suppository.The vagina suppository can not be goed deep into the deep tissues of inflammation, also can not effectively suppress the hypertrophy of body of gland; Through long-term suppository, though the phenomenon of taking a favorable turn, but might recur again again in a short time, be difficult to radical cure.
4, cervicitis sickness rate height adopts suppository extremely inconvenient, brings difficulty to the patient.
5, cervicitis adopt that tapered excision of cervix uteri or uterus are excised fully, freezing, fomentation, radioactive isotope therapy etc. because treatment is traumatic big, the patient is beyond affordability.
6, neck body blood flow in uterus is low, and the vagina suppository can not be goed deep into the cervical tissue deep layer, causes the long-term hypertrophy of body of gland, and the formative tissue fibrosis causes cervical hypertrophy.
The objective of the invention is shortcoming, utilize interior disease outer treating method, propose gynopathic external used medicine of a kind of treatment and preparation method thereof at existing Therapeutic Method and medicine.
The component and the parts by weight thereof of the gynopathic external used medicine of treatment of the present invention are:
Squama Manis 20-25 part Radix Sophorae Flavescentis 30-40 part Cortex Phellodendri 40-55 part
Herba Artemisiae Anomalae 20-35 part Cortex Fraxini 30-45 part Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 30-45 part
Rhizoma Corydalis 20-30 part Herba Patriniae 30-40 part Pericarpium Citri Reticulatae 20-25 part
Rhizoma Polygoni Cuspidati 40-55 part Rhizoma Smilacis Glabrae 40-50 part Fructus Aurantii 30-40 part
Oletum Trogopterori 20-35 part Radix Arnebiae (Radix Lithospermi) 20-30 part Rhizoma Cyperi 20-35 part
Flos Rosae Chinensis 40-60 part Fructus Forsythiae 20-30 part Rhizoma Pinelliae 20-25 part
Rhizoma sparganic 30-45 part Ramulus Salicis Babylonicae 30-60 part Rhizoma Arisaematis (processed) 20-25 part
Rhizoma Curcumae 30-45 part Cortex Pseudolaricis 40-50 part or
Squama Manis 20-25 part Radix Sophorae Flavescentis 30-40 part Cortex Phellodendri 30-45 part
Herba Artemisiae Anomalae 10-25 part Cortex Fraxini 20-35 part Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 20-35 part
Rhizoma Corydalis 20-30 part Herba Patriniae 30-40 part Pericarpium Citri Reticulatae 20-25 part
Rhizoma Polygoni Cuspidati 30-45 part Rhizoma Smilacis Glabrae 20-30 part Fructus Aurantii 30-40 part
Oletum Trogopterori 20-35 part Radix Arnebiae (Radix Lithospermi) 20-30 part Rhizoma Cyperi 20-35 part
Flos Rosae Chinensis 40-60 part Fructus Forsythiae 10-20 part Rhizoma Pinelliae 20-25 part
Rhizoma sparganic 30-45 part Ramulus Salicis Babylonicae 30-60 part Rhizoma Arisaematis (processed) 20-25 part
Rhizoma Curcumae 30-45 part Cortex Pseudolaricis 20-35 part
Its preparation method and key step thereof comprise:
1) 120 order powder will be ground into earlier after the Squama Manis vinegar system;
2) again Herba Artemisiae Anomalae, Rhizoma Corydalis, Rhizoma Polygoni Cuspidati, Oletum Trogopterori, Flos Rosae Chinensis, rhizoma sparganic, Rhizoma Curcumae, Radix Sophorae Flavescentis, Cortex Fraxini, Herba Patriniae, Rhizoma Smilacis Glabrae, Radix Arnebiae (Radix Lithospermi), Fructus Forsythiae, Ramulus Salicis Babylonicae, Cortex Pseudolaricis, Cortex Phellodendri, Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus), Pericarpium Citri Reticulatae, Fructus Aurantii, Rhizoma Cyperi, Rhizoma Pinelliae and Rhizoma Arisaematis (processed) are ground into 120 order powder.
3) above-mentioned 23 kinds of herbal powders are made loose powder by its parts by weight mixing;
4) above-mentioned powder is concentrated through organic solvent extraction, under the condition of high temperature, carry out ripening, after sterilization treatment, get finished product powder again;
5) above-mentioned powder being become inner face through hot press moulding is cloth cover, and the outside is the packed tablet of plastic film or extrusion coating paper cloth cover, and each packed tablet contains Chinese herbal medicine powder weight 3.3-6.6 part.
Described ripening sterilization treatment adopts step type cooling ripening sterilizing methods, and temperature is risen to 110 ℃ rapidly, and segmentation drops to 100 ℃ again, and the time is 30-45 minute.
Research and development proposal of the present invention is based at the gynecological diseases summary of clinical treatment experience for many years, think that theoretically gynecological diseases has blood stasis essence, use for reference the principle of motherland's traditional medicine to gynecological diseases activating blood and resolving stasis and treating method, theoretical basis in conjunction with inner disease outer treat, with reference to the modern pharmacological research achievement, from motherland medicine treasure-house, in filter out that blood circulation promoting and blood stasis dispelling, choosing add dehumidifying, reduce phlegm, heat clearing away, detoxifcation, germ-resistant Chinese herbal medicine, form through the modern scientific method refining refinement.It is characterized in that nourishing kidney-yin, QI invigorating void, blood stasis dispelling blood, pure and impurely let out, go tiltedly to set upright, taking stopgap measures consolidates, and according to the theory of Chinese medical science prescription, skims the cream off milk, microcirculation improvement is promoted the histiocyte founction metabolism, impels the pathological tissues reparation.
The major advantage of the gynopathic external used medicine of treatment of the present invention is that it has blood circulation promoting and blood stasis dispelling, improves the pelvic tissue blood circulation, the enhancing human body immunity function; Change the founction metabolism of pelvic tissue organ, impel the local organization cell hypoxia to improve, make endocrine, ooze out minimizing, thereby reach the purpose of healing.
Embodiment 1:
The component and the parts by weight thereof for the treatment of gynopathic external used medicine are:
48 parts of 35 portions of Cortex Phellodendris of 22 parts of Radix Sophorae Flavescentiss of Squama Manis
38 parts of 38 portions of Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus)s of 30 parts of Cortex Fraxinis of Herba Artemisiae Anomalae
22 parts of 35 parts of Pericarpium Citri Reticulataes of 25 parts of Herba Patriniae of Rhizoma Corydalis
35 parts of 45 parts of Fructus Aurantiis of 50 parts of Rhizoma Smilacis Glabraes of Rhizoma Polygoni Cuspidati
30 parts of 25 portions of Rhizoma Cyperis of 30 portions of Radix Arnebiae (Radix Lithospermi)s of Oletum Trogopterori
22 parts of 25 parts of Rhizoma Pinelliae of 50 parts of Fructus Forsythiaes of Flos Rosae Chinensis
22 parts of 45 parts of Rhizoma Arisaematis (processed) of 35 parts of Ramulus Salicis Babylonicaes of rhizoma sparganic
45 parts of 40 parts of Cortex Pseudolaricis of Rhizoma Curcumae
Embodiment 2:
The preparation method of the Chinese herb medicine among the embodiment 1, its step comprises:
1) 120 order powder will be ground into earlier after the Squama Manis vinegar system;
2) again 22 Chinese medicine powders such as Herba Artemisiae Anomalae are broken into 120 order powder.
3) make loose powder by its umber mixing;
4) concentrate through organic solvent extraction, and with step type lower the temperature ripening, sterilization treatment, the time is 40 minutes, finished product powder;
5) after hot press moulding becomes inner face is cloth cover, the outside is the packed tablet of plastic film layer, and inlays the Nd-Fe-B permanent magnetic iron plate on the plastic film layer, and every tablet of tablet contains 3.5 parts of Chinese herbal medicine powders, and every medicated bag is 2 * 2cm, thick 0.5cm.Magnetic sheet is the polygon of thick 0.3cm.

Claims (4)

1, the gynopathic external used medicine of a kind of treatment is characterized in that its component and parts by weight thereof are:
Squama Manis 20-25 part Radix Sophorae Flavescentis 30-40 part Cortex Phellodendri 40-55 part
Herba Artemisiae Anomalae 20-35 part Cortex Fraxini 30-45 part Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 30-45 part
Rhizoma Corydalis 20-30 part Herba Patriniae 30-40 part Pericarpium Citri Reticulatae 20-25 part
Rhizoma Polygoni Cuspidati 40-55 part Rhizoma Smilacis Glabrae 40-50 part Fructus Aurantii 30-40 part
Oletum Trogopterori 20-35 part Radix Arnebiae (Radix Lithospermi) 20-30 part Rhizoma Cyperi 20-35 part
Flos Rosae Chinensis 40-60 part Fructus Forsythiae 20-30 part Rhizoma Pinelliae 20-25 part
Rhizoma sparganic 30-45 part Ramulus Salicis Babylonicae 30-60 part Rhizoma Arisaematis (processed) 20-25 part
Rhizoma Curcumae 30-45 part Cortex Pseudolaricis 40-50 part
2, the gynopathic external used medicine of a kind of treatment is characterized in that its component and parts by weight thereof are:
Squama Manis 20-25 part Radix Sophorae Flavescentis 30-40 part Cortex Phellodendri 30-45 part
Herba Artemisiae Anomalae 10-25 part Cortex Fraxini 20-35 part Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus) 20-35 part
Rhizoma Corydalis 20-30 part Herba Patriniae 30-40 part Pericarpium Citri Reticulatae 20-25 part
Rhizoma Polygoni Cuspidati 30-45 part Rhizoma Smilacis Glabrae 20-30 part Fructus Aurantii 30-40 part
Oletum Trogopterori 20-30 part Radix Arnebiae (Radix Lithospermi) 20-30 part Rhizoma Cyperi 20-35 part
Flos Rosae Chinensis 40-60 part Fructus Forsythiae 10-20 part Rhizoma Pinelliae 20-25 part
Rhizoma sparganic 30-45 part Ramulus Salicis Babylonicae 30-60 part Rhizoma Arisaematis (processed) 20-25 part
Rhizoma Curcumae 30-45 part Cortex Pseudolaricis 20-35 part
3, a kind of preparation method for the treatment of gynopathic external used medicine, its key step comprises:
1) 120 order powder will be ground into earlier after the Squama Manis vinegar system;
2) again Herba Artemisiae Anomalae, Rhizoma Corydalis, Rhizoma Polygoni Cuspidati, Oletum Trogopterori, Flos Rosae Chinensis, rhizoma sparganic, Rhizoma Curcumae, Radix Sophorae Flavescentis, Cortex Fraxini, Herba Patriniae, Rhizoma Smilacis Glabrae, Radix Arnebiae (Radix Lithospermi), Fructus Forsythiae, Ramulus Salicis Babylonicae, Cortex Pseudolaricis, Cortex Phellodendri, Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus), Pericarpium Citri Reticulatae, Fructus Aurantii, Rhizoma Cyperi, Rhizoma Pinelliae and Rhizoma Arisaematis (processed) are ground into 120 order powder.
3) above-mentioned 23 kinds of herbal powders are made loose powder by its parts by weight mixing;
4) above-mentioned powder is concentrated through organic solvent extraction, under the condition of high temperature, carry out ripening, after sterilization treatment, get finished product powder again;
5) above-mentioned powder being become inner face through hot press moulding is cloth cover, and the outside is the packed tablet of plastic film or extrusion coating paper cloth cover, and each packed tablet contains Chinese herbal medicine powder weight 3.3-6.6 part.
4, preparation method as claimed in claim 3 is characterized in that described ripening sterilization treatment adopts step type cooling ripening sterilizing methods, and temperature is risen to 110 ℃ rapidly, and segmentation drops to 100 ℃ again, and the time is 30-45 minute.
CN 97116339 1997-08-14 1997-08-14 External-use medicines for treating gynaopathy and its prepn. method Pending CN1173372A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97116339 CN1173372A (en) 1997-08-14 1997-08-14 External-use medicines for treating gynaopathy and its prepn. method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97116339 CN1173372A (en) 1997-08-14 1997-08-14 External-use medicines for treating gynaopathy and its prepn. method

Publications (1)

Publication Number Publication Date
CN1173372A true CN1173372A (en) 1998-02-18

Family

ID=5173776

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97116339 Pending CN1173372A (en) 1997-08-14 1997-08-14 External-use medicines for treating gynaopathy and its prepn. method

Country Status (1)

Country Link
CN (1) CN1173372A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326465C (en) * 2001-08-08 2007-07-18 沈保安 Orange tea prepared by using trifoliate orange as the material
CN101461916B (en) * 2008-08-11 2011-03-16 王雷 External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same
CN104147322A (en) * 2014-08-16 2014-11-19 冯莉华 Pharmaceutical composition for treating cervical erosion

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326465C (en) * 2001-08-08 2007-07-18 沈保安 Orange tea prepared by using trifoliate orange as the material
CN101461916B (en) * 2008-08-11 2011-03-16 王雷 External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same
CN104147322A (en) * 2014-08-16 2014-11-19 冯莉华 Pharmaceutical composition for treating cervical erosion

Similar Documents

Publication Publication Date Title
CN1162171C (en) Gynopathy treating traditional Chinese medicine
CN1286490C (en) anti inflammation decoction for treating morbid leucorrhea, etc.
CN1446558A (en) Blaster for treating rheumatoid arthritis
CN101041033A (en) Chinese medicine for treating hepatitis B
CN1742979A (en) Chinese medicine for treating proliferation of mammary gland
CN1813955A (en) Medicine for treating tympanitis and otitis externa, and preparing method
CN1332702C (en) Medicine for treating psoriasis
CN1189201C (en) Externally applied Chinese medicine for treating osteoarthropathy and its prepn process
CN1173372A (en) External-use medicines for treating gynaopathy and its prepn. method
CN103417879A (en) Drug for treatment of psoriasis
CN1061551C (en) Traditional Chinese medicine for curing leukoplakia vulvae of gynecopathy
CN1266705A (en) Chinese-medicinal pills for treating rheumatism and preparing process thereof
CN1048324A (en) The manufacture method of stone-dissolving medicine " Rongshibao "
CN1478525A (en) Medicated wine for treating traumatic injury
CN1357362A (en) Stone-eliminating Jinyin medicine powder
CN1319587C (en) Medicine powder for liver and spleen diseases
CN1742955A (en) Chinese medicine for treating nipple discharge
CN1260209A (en) Medicine for nephritis--Shenyanling
CN1058189C (en) External- and thermal-mounted trauma medicinal powder bag
CN1062480C (en) Oral liquor for curing urethritis
CN1857459A (en) Capsule for treating women's inflammation
CN1772126A (en) Antiphlogistic medicine
CN1114885A (en) External-use medicine powder for health care, nourishing kidney and clearing brain
CN1857514A (en) Chinese medicine composition for treating piles and its preparation
CN1682858A (en) Adhesive umbilicus powder for removing spot

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication